Studies
-
Status: Archived
Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen
Archived by: Holly Baker | 2nd August 2022
-
Status: Archived
Treating children for drug-resistant tuberculosis in Tajikistan with Group 5 medications
Archived by: Holly Baker | 1st August 2022
-
Status: Study was withdrawn or postponed
Ebola in children; a description of presenting symptoms of seven children with Ebola
-
Status: Archived
Effectiveness of TB treatment regimens containing bedaquiline for Extensively Drug Resistant Tuberculosis patients in Chechnya
Archived by: Holly Baker | 10th August 2022
-
Status: Archived
Bedaquiline use in adolescents and children with drug-resistant tuberculosis: a descriptive cohort study
Archived by: 'System'
-
Status: Archived
Culture conversion rates on the short course MDR-TB treatment regimen compared with standard of care in Uzbekistan
Archived by: 'System'
-
Status: Archived
Impact of programmatic reduction in PAS use on patient adherance during MDR-TB treatment
Archived by: 'System'
-
Status: Archived
Multi-centric analysis of drug-resistant tuberculosis patients treated with Delamanid (Dlm) in MSF projects site: a short communication
Archived by: Holly Baker | 10th August 2022
-
Status: Archived
Children and adolescents on treatment for extensively drug resistant tuberculosis: a descriptive cohort study
Archived by: Holly Baker | 10th August 2022
-
Status: Archived
Extensively drug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan: a cohort study
Archived by: Holly Baker | 10th August 2022
-
Status: Completion
Cost Effectiveness of the Shorter Course MDR TB Regimen (SCR) for multi-drug resistant tuberculosis (MDR TB) treatment
-
Status: Archived
Treatment outcomes of drug-sensitive, MDR and XDR tuberculosis amongst individuals with diabetes in the Chechen Republic, Russian Federation.
Archived by: Holly Baker | 10th August 2022
-
Status: Completion
Association between bedaquiline use and QT interval: a cohort analysis of data from a drug-resistant tuberculosis programme in Chechnya and Uzbekistan
-
Status: Completion
Analysis of the diagnostic accuracy of the molecular methods for predicting drug resistance in tuberculosis patients in Karakalpakstan (Uzbekistan)
-
Status: Completion
Pericardial DR-TB in a child treated in Tajikistan: A case description
-
Status: Study was withdrawn or postponed
Identifying risk factors for HIV acquisition in a cohort of children with undetermined transmission mode in Khatlon/Kulon region, Republic of Tajikistan.
-
Status: Archived
Bedaquiline in the treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan: a historical cohort study
Archived by: Holly Baker | 10th August 2022